Document Detail


Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
MedLine Citation:
PMID:  21349396     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Pulmonary arterial hypertension (PAH) is a rare and progressive disease of the pulmonary arterial circulation that is characterized by a progressive rise in pulmonary vascular resistance, eventually leading to right-heart failure and death. There are currently 3 classes of drugs approved for the treatment of PAH: prostacyclin analogues, endothelin receptor antagonists, and phosphodiesterase type 5 inhibitors. All of these therapies have been approved for use on the basis of relatively small, short-term studies, yet it is common for each to be administered (alone or in combination) over the lifetime of a patient with PAH. Very few prospective, well-controlled PAH studies have examined long-term clinical outcomes associated with current medical therapy. Therefore, data that support the long-term therapeutic benefits of these long-term PAH therapies are limited and derived primarily from uncontrolled, observational studies. In this perspective, the authors review the published research to assess the strengths and weaknesses of the data that support the long-term clinical benefit of current PAH therapies. The authors conclude that current medical therapies approved for the treatment of PAH can provide sustained benefits in hemodynamic function and exercise capacity. The cumulative evidence, in the form of meta-analysis and registry data, suggest that patients are living longer compared with untreated patients; the reasons are likely multifactorial. Although definitive evidence will require randomized and properly controlled long-term trials, the current evidence supports the long-term use of these drugs for the treatment of patients with PAH.
Authors:
Mardi Gomberg-Maitland; Christopher Dufton; Ronald J Oudiz; Raymond L Benza
Related Documents :
3491666 - Atherosclerosis of coronary artery bypass grafts and smoking.
9423706 - Use of arm and lesser saphenous vein compared with prosthetic grafts for infrapopliteal...
4045146 - The use of y-shaped interposition vein grafts in multiple digit replantations.
10743896 - Axillary artery anastomosis to avoid axillofemoral bypass disruption.
6103926 - Multiple aneurysms of visceral arteries in a child with polyarteritis nodosa.
15280066 - Effect of venous air embolization on pulmonary microvascular protein permeability.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  57     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1053-61     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Affiliation:
University of Chicago Medical Center, Chicago, Illinois.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pituitary melanocytoma mimicking an adenoma.
Next Document:  The Valve-in-Valve Technique for Treatment of Aortic Bioprosthesis Malposition An Analysis of Incide...